Here are five insights:
1. After a seven-day trial and five hours of deliberation, a Wisconsin jury found DePuy companies willfully infringed Acantha’s patent. The jury delivered the unanimous verdict Aug. 21.
2. In a 2015 lawsuit, Acantha accused DePuy Synthes of infringing on Acantha’s patent for an orthopedic implant assembly designed to join bone segments.
3. During the trial, the plaintiffs said patent co-inventor David Talaber informed DePuy Synthes’ predecessors about the patent both in writing and by phone.
4. The other co-inventor James Lloyd, MD, reportedly explained how the patent could alleviate DePuy’s implant device problems during a later visit to DePuy’s headquarters
5. The DePuy companies did not license the patent. Acantha claimed DePuy Synthes then infringed the patent in the Zero-P VA System and Vectra, Vectra-T and Vectra-One products, as well as other spine implant devices.
More articles on supply chain:
ASC supply chain tip of the day: Utilize automation
Steadman Clinic, Vail-Summit Orthopaedics propose 80-100K-sq-ft. surgery center
3 ways ASCs can avoid infection control lapses
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.